Guangzhou Astraglaxo Bio-pharmaceutical Co., Ltd

Country/Region: China     State/Province: Guangdong

Main Products: Astragaloside IV, Cycloastragenol, TA65

Company Introduction
Astragaloside IV,Cycloastragenol,TA65
Company Overview

Business Type: Supplier, Buying House

Year Established: 2007

Employees: Above 1000 People

Plant Area: 10,000-30,000 square meters

Business Information

Main Markets: South America 8% Africa 12% Eastern Asia 12% Domestic Market 12% North America 11% Eastern Europe 8% Southern Europe 11% Mid East 12% Northern Europe 8% Oceania 6%

Trade Capacity: FOB, FAS, DDP

Contract Manufacturing: OEM Service Offered Design Service Offered Buyer Label Offered

Nearest Port: Guangzhou

Trade & Financial Information

Annual Revenue: US$5 Million - US$10 Million

Total Revenue: Above US$100 Million

Export Revenue: confidential

Annual Output: US$5 Million - US$10 Million

Registered Capital: US$2.5 Million - US$5 Million

Export Percentage: 1% - 10%

Payment Modes: USD, JPY, HKD

Lead Time: 32 days

Import/Export Mode: Have Own Export License

Product Showcase
Astragaloside IV
Cycloastragenol
TA65

CL-Link > Health & Medicines in China Health & Medicines in Guangdong Plant Extracts in China Plant Extracts in Guangdong